Matthew Sykes

Work

Analyst Matthew Sykes works at GOLDMAN SACHS and is focused on the Healthcare sector with 197 price targets and ratings documented since 2012 spanning on 23 stocks. Analyst's average stock valuation to be materialised ratio is 35.79% with an average time for price targets to be met of 88.33 days.

Most recent stock forecast was given on MTD, Mettler-Toledo International Inc at 08-Nov-2022.

Matthew Sykes best performing recommendations are on ZY (ZYMERGEN INC).
The best stock recommendation documented was for ZY (ZYMERGEN INC) at 8/4/2021. The price target of $12 was fulfilled within 1 day with a profit of $3.75 (45.45%) receiving and performance score of 454.55.

Average potential price target upside

DHR MRVI NAUT NTRA NVTA PKI TMO TXG WAT ZY OMIC GH MYGN NEO QTRX CTKB HLTH OLK TX CDNA MTD SMFR AVTR
DHR MRVI NAUT NTRA NVTA PKI TMO TXG WAT ZY OMIC GH MYGN NEO QTRX CTKB HLTH OLK TX CDNA MTD SMFR AVTR